Difference between revisions of "iSenseCorp.com"
(→Products) |
|||
| Line 13: | Line 13: | ||
== Products == | == Products == | ||
| − | *iSense microsensor Unlike traditional modes of glucose detection, iSense's implanted glucose microsensors continually monitor glucose levels in the body, providing the patient with constant biofeedback. Their sensors can give earlier warnings of the onset of hypoglycemia or hyperglycemia, thereby allowing the patient to find treatment faster. | + | *iSense microsensor Unlike traditional modes of glucose detection, iSense's implanted glucose microsensors continually monitor glucose levels in the body, providing the patient with constant biofeedback. Their sensors can give earlier warnings of the onset of hypoglycemia or hyperglycemia, thereby allowing the patient to find treatment faster. <br><br> |
: Read their article on [http://www.isensecorp.com/reason.htm The Reasons For Continuous Glucose Monitoring] | : Read their article on [http://www.isensecorp.com/reason.htm The Reasons For Continuous Glucose Monitoring] | ||
Revision as of 16:48, 23 October 2007
iSense - Glucose Sensors
Products
- iSense microsensor Unlike traditional modes of glucose detection, iSense's implanted glucose microsensors continually monitor glucose levels in the body, providing the patient with constant biofeedback. Their sensors can give earlier warnings of the onset of hypoglycemia or hyperglycemia, thereby allowing the patient to find treatment faster.
- Read their article on The Reasons For Continuous Glucose Monitoring
People
- Richard G. Sass - Founder, CEO
- W. Kenneth Ward, MD - Chief Scientific Officer
- Jane K. Conner,CPA - Chief Financial Officer
- Jody L. House, Sc.D. - Senior Scientist
- Bob Bruce, PhD - Director of Biomedical Engineering
- Gary Lichttenegger - Director of Regulatory Affiars/Quality Assurance
Consulting Team
- Russell O. Potts, PhD
- Geoffrey A. Russell, PhD
